Optimal working dilution should be determined by the investigator.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Liquid
Konzentration
0.25 mg/mL
Buffer
Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification.
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Handhabung
Avoid repeated freezing and thawing.
Lagerung
4 °C/-20 °C
Informationen zur Lagerung
Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
Target
HMGN3
(High Mobility Group Nucleosomal Binding Domain 3 (HMGN3))
Trip7 antikoerper, PNAS-25 antikoerper, TRIP7 antikoerper, 1110002A15Rik antikoerper, 6330514M13Rik antikoerper, BB071015 antikoerper, high mobility group nucleosomal binding domain 3 L homeolog antikoerper, high mobility group nucleosomal binding domain 3 antikoerper, hmgn3.L antikoerper, HMGN3 antikoerper, Hmgn3 antikoerper
Hintergrund
Thyroid hormone receptors are hormone-dependent transcription factors that regulate expression of a variety of specific target genes. The protein encoded by this gene binds thyroid hormone receptor beta, but only in the presence of thyroid hormone. The encoded protein, a member of the HMGN protein family, is thought to reduce the compactness of the chromatin fiber in nucleosomes, thereby enhancing transcription from chromatin templates. Two transcript variants encoding different isoforms have been found for this gene.Synonyms: High mobility group nucleosome-binding domain-containing protein 3, PNAS-24, TR-interacting protein 7, Thyroid receptor-interacting protein 7